| Product Code: ETC13261150 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Infectious Disease Molecular Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Infectious Disease Molecular Diagnostics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Infectious Disease Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Infectious Disease Molecular Diagnostics Market - Industry Life Cycle |
3.4 North America Infectious Disease Molecular Diagnostics Market - Porter's Five Forces |
3.5 North America Infectious Disease Molecular Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Infectious Disease Molecular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 North America Infectious Disease Molecular Diagnostics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
3.8 North America Infectious Disease Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 North America Infectious Disease Molecular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Infectious Disease Molecular Diagnostics Market Trends |
6 North America Infectious Disease Molecular Diagnostics Market, 2021 - 2031 |
6.1 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Instruments, 2021 - 2031 |
6.1.3 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Reagents, 2021 - 2031 |
6.1.4 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Services, 2021 - 2031 |
6.2 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.3 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.2.4 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Diagnostics Laboratories, 2021 - 2031 |
6.2.5 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021 - 2031 |
6.3.3 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By In Situ Hybridization, 2021 - 2031 |
6.3.4 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Isothermal Nucleic Acid Amplification Technology (INAAT), 2021 - 2031 |
6.3.5 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Chips and Microarrays, 2021 - 2031 |
6.3.6 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Mass Spectrometry, 2021 - 2031 |
6.3.7 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Sequencing, 2021 - 2031 |
6.3.8 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Transcription Mediated Amplification, 2021 - 2031 |
6.3.9 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Infectious Disease Molecular Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.1 United States (US) Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.2 Canada Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.3 Rest of North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3 North America Infectious Disease Molecular Diagnostics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
7.3.1 United States (US) Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.3.2 Canada Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.3.3 Rest of North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.4 North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.1 United States (US) Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.2 Canada Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4.3 Rest of North America Infectious Disease Molecular Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 North America Infectious Disease Molecular Diagnostics Market Key Performance Indicators |
9 North America Infectious Disease Molecular Diagnostics Market - Export/Import By Countries Assessment |
10 North America Infectious Disease Molecular Diagnostics Market - Opportunity Assessment |
10.1 North America Infectious Disease Molecular Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Infectious Disease Molecular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 North America Infectious Disease Molecular Diagnostics Market Opportunity Assessment, By End-use, 2021 & 2031F |
10.4 North America Infectious Disease Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 North America Infectious Disease Molecular Diagnostics Market - Competitive Landscape |
11.1 North America Infectious Disease Molecular Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 North America Infectious Disease Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here